Evolutionary Genomics (FNAM) Stock Statistics & Valuation Metrics

Evolutionary Genomics has a market cap or net worth of $1.33K. The enterprise value is $3.17M.

Evolutionary Genomics has 6,655,232 shares outstanding. The number of shares has decreased by -2.65% in one year.

Evolutionary Genomics’s return on equity (ROE) is 1.23 and return on invested capital (ROIC) is -92.59%.

The current PE Ratio of Evolutionary Genomics is ―. Evolutionary Genomics’s PEG ratio is 0.07.

In the last 12 months, Evolutionary Genomics had revenue of 0.00 and earned -1.93M in profits. Earnings per share was -0.35.

In the last 12 months, operating cash flow was -640.95K and capital expenditures 0.00, giving a free cash flow of -640.95K billion.

Evolutionary Genomics pays an annual dividend of ―, resulting in a dividend yield of ―

Evolutionary Genomics upcoming earnings date is May 15, 2018, Before Open (Confirmed).

Evolutionary Genomics as a current ratio of 3.92, with Debt / Equity ratio of -238.72%

In the past 12 months, Evolutionary Genomics has paid 0.00 in taxes.

Evolutionary Genomics EV to EBITDA ratio is -8.39, with an EV/FCF ratio of -11.96.

Evolutionary Genomics has $577.07K in cash and marketable securities with $3.74M in debt, giving a net cash position of -$3.17M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Evolutionary Genomics is ―, which is 11.43% higher than the current price. The consensus rating is ―